| DrugBank ID |
Name |
Formula |
Weight |
DB01193
|
Acebutolol |
C18H28N2O4 |
336.4259 |
| Acebutolol Acebutolol Pathway SMP00296 Acebutolol is a cardioselective, beta-adrenoreceptor blocking agent, which possesses mild intrinsic sympathomimetic activity (ISA) in its therapeutically ... |
DB00236
|
Pipobroman |
C10H16Br2N2O2 |
356.0540 |
| Acebutolol Antagonism
Atenolol Antagonism
Betaxolol Antagonism
Bevantolol Antagonism
Bisoprolol Antagonism
Carteolol Antagonism
Carvedilol Antagonism
Esmolol Antagonism
Labetalol Antagonism ... |
DB00983
|
Formoterol |
C19H24N2O4 |
344.4049 |
| Acebutolol Antagonism
Atenolol Antagonism
Betaxolol Antagonism
Bevantolol Antagonism
Bisoprolol Antagonism
Carteolol Antagonism
Carvedilol Antagonism
Esmolol Antagonism
Labetalol Antagonism ... |
DB01288
|
Fenoterol |
C17H21NO4 |
303.3529 |
| Acebutolol Antagonism
Alseroxylon Increased arterial pressure
Amitriptyline The tricyclic increases the sympathomimetic effect
Amoxapine The tricyclic increases the sympathomimetic effect
Atenolol ... |
DB00816
|
Orciprenaline |
C11H17NO3 |
211.2576 |
| Acebutolol Antagonism
Alseroxylon Increased arterial pressure
Amitriptyline The tricyclic increases the sympathomimetic effect
Amoxapine The tricyclic increases the sympathomimetic effect
Atenolol ... |
DB00871
|
Terbutaline |
C12H19NO3 |
225.2842 |
| Acebutolol Antagonism
Alseroxylon Increased arterial pressure
Amitriptyline The tricyclic increases the sympathomimetic effect
Amoxapine The tricyclic increases the sympathomimetic effect
Atenolol ... |
DB00247
|
Methysergide |
C21H27N3O2 |
353.4580 |
| ... YBSCGTCVDI For the treatment of vascular headache Acebutolol Ischemia with risk of gangrene
Almotriptan Possible severe and prolonged vasoconstriction
Amyl Nitrite Possible antagonism of ... |
DB00457
|
Prazosin |
C19H21N5O4 |
383.4011 |
| Acebutolol Risk of hypotension at the beginning of therapy
Atenolol Risk of hypotension at the beginning of therapy
Betaxolol Risk of hypotension at the beginning of therapy
Bevantolol Risk of ... |
DB00554
|
Piroxicam |
C15H13N3O4S |
331.3460 |
| Acebutolol Risk of inhibition of renal prostaglandins
Acenocoumarol The NSAID increases the anticoagulant effect
Alendronate Increased risk of gastric toxicity
Anisindione The NSAID increases the ... |
DB00575
|
Clonidine |
C9H9Cl2N3 |
230.0940 |
| ... of migraine or recurrent vascular headache; Menopausal flushing Acebutolol Increased hypertension when clonidine stopped
Amitriptyline The tricyclic decreases the effect of clonidine
Amoxapine ... |
DB01050
|
Ibuprofen |
C13H18O2 |
206.2808 |
| ... and rheumatic), sprains, strains, backache and neuralgia Acebutolol Risk of inhibition of renal prostaglandins
Acenocoumarol The NSAID increases the anticoagulant effect
Alendronate Increased ... |
DB00280
|
Disopyramide |
C21H29N3O |
339.4745 |
| Acebutolol The beta-blocker increases toxicity of disopyramide
Atenolol The beta-blocker increases toxicity of disopyramide
Azithromycin The macrolide increases the effect of disopyramide ... |
DB00328
|
Indomethacin |
C19H16ClNO4 |
357.7880 |
| Acebutolol Risk of inhibition of renal prostaglandins
Acenocoumarol The NSAID increases the anticoagulant effect
Alendronate Increased risk of gastric toxicity
Anisindione The NSAID increases the ... |
DB00414
|
Acetohexamide |
C15H20N2O4S |
324.3950 |
| Acebutolol The beta-blocker decreases the symptoms of hypoglycemia
Aspirin The salicylate increases the effect of sulfonylurea
Atenolol The beta-blocker decreases the symptoms of hypoglycemia ... |
DB00672
|
Chlorpropamide |
C10H13ClN2O3S |
276.7400 |
| Acebutolol The beta-blocker decreases the symptoms of hypoglycemia
Aspirin The salicylate increases the effect of sulfonylurea
Atenolol The beta-blocker decreases the symptoms of hypoglycemia ... |
DB00912
|
Repaglinide |
C27H36N2O4 |
452.5857 |
| Acebutolol The beta-blocker decreases the symptoms of hypoglycemia
Acetohexamide Similar mode of action - questionable association
Atenolol The beta-blocker decreases the symptoms of hypoglycemia ... |
DB01120
|
Gliclazide |
C15H21N3O3S |
323.4110 |
| ... XQMQJMAZCQ For the treatment of Diabetes mellitus Acebutolol The beta-blocker decreases the symptoms of hypoglycemia
Aspirin The salicylate increases the effect of sulfonylurea
Atenolol The ... |
DB01162
|
Terazosin |
C19H25N5O4 |
387.4329 |
| Acebutolol Increased risk of hypotension. Initiate concomitant therapy cautiously.
Alfuzosin Additive antihypertensive effects may occur. Increase risk of orthostatic hypotension and syncope. |
DB01308
|
Insulin-glargine |
C267H408N72O77S6 |
6050.9226 |
| DB01308 Acebutolol The beta-blocker decreases the symptoms of hypoglycemia
Aspirin The salicylate increases the effect of insulin
Atenolol The beta-blocker decreases the symptoms of hypoglycemia ... |
DB01016
|
Glibenclamide |
C23H28ClN3O5S |
494.0040 |
| Acebutolol The beta-blocker decreases the symptoms of hypoglycemia
Aspirin The salicylate increases the effect of sulfonylurea
Atenolol The beta-blocker decreases the symptoms of hypoglycemia ... |